Understanding clinical decision-making during the COVID-19 pandemic: A cross-sectional worldwide survey.

ABSTRACT:

Background

The lack of evidence-based recommendations for therapeutic decisions during the early weeks of the COVID-19 pandemic creates a unique scenario of clinical decision making which is worth to analyze. We aim to identify the drivers of therapeutic aggressiveness during the first weeks of the COVID-19 pandemic.

Methods

This cross-sectional worldwide survey (conducted April 12 to 19, 2020) was aimed at physicians who managed patients diagnosed with COVID-19. Treatment preferences were collected in five different clinical scenarios. We used multilevel mixed-effects ordered logistic regression to identify variables that were associated with the use of more aggressive therapies.

Findings

The survey was completed by 852 physicians from 44 different specialties and 29

SUBMITTER: Martinez-Sanz J 

PROVIDER: S-EPMC7480231 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature